Bidet startup Tushy scales up to meet demand amid toilet paper shortage

Business at Tushy is booming.

While the circumstances that led to the boom are sobering, the bidet company needed to adapt its strategy after seeing an uptick in business amid the COVID-19 pandemic. Other companies in this cohort include video conferencing service Zoom, meal kit service Blue Apron and Facebook, thanks to its social network, video hardware Portal and Oculus Quest VR headset. These companies all have something in common — they offer solutions to problems that, until recently, were not all that urgent.

Founded in 2015 by Thinx founder Miki Agrawal, Tushy aims to replace toilet paper, CEO Jason Ojalvo tells TechCrunch. Ojalvo, who joined the company as CEO in 2018, says North America has been a holdout when it comes to bidets. As a result, the nation flushes about 15 million trees down the toilet every year.

Tushy, which has raised $2.9 million since its founding, has been profitable for the last two years. That’s in part thanks to the company’s focus on sustainability — not just from an environmental standpoint, but from a business one, Ojalvo says. That means not over-hiring or spending too much on marketing.

“We’re really careful about doing it in a way so we won’t explode like some other direct-to-consumer companies can do when they raise too much money and they over-hire and then they have to let people go,” Ojalvo says. “That’s just a debacle that I’ve seen first hand and I don’t want to be part of it. Not only do I not want to be part of it but I don’t want to be the leader of the company that does that.”

Prior to the coronavirus pandemic, Tushy saw its growth double year-over-year. Ojalvo says that’s partly been a result of having customers who evangelize on their behalf. Fast-forward to around March 9, when sales really started to double beyond the norm; a few days later, Tushy was having days where it brought in $500,000 in sales.

COVID-19 crisis spurs triple-digit growth for refurbishing startup Back Market

While a number of startups have been hard hit by efforts to curb the spread of the COVID-19 virus, refurbishing firm Back Market is showing increased growth globally.

The Paris -based startup encourages customers to send in their old devices so they can be refurbished and resold into the e-commerce secondhand market. The growth achieved in the midst of the COVID-19 crisis is partly due to increased laptop sales as people seek better devices to work remotely.

For people who are unsure whether refurbished products are reliable, Back Market permits customers to send in old devices, exchange them for newer versions and pay the difference. CEO Thibaud Hug de Larauze said this payback service is currently possible only in France, but starting in Q2, it will be available in other markets.

Founded in 2014, Back Market has raised a total of €48 million in funding over two rounds, most recently a Series B in June 2018. The company is profitable and reportedly still has money to spend from its last funding round.

“We don’t release the gross merchandise volume, but it’s a three-digit growth rate,” Hug de Larauze told TechCrunch. “We saw an increase in demand for laptops, printers and other devices needed for working at home. Demand for refurbished phones is going down as people seek to get the first necessity items, like food for their situation.”

Over the past two weeks, Back Market saw skyrocketing demand from Italy, a nation with a high coronavirus death toll where citizens were warned they would be confined to their homes for four weeks.

Another factor that helped the platform’s growth: Smartphone brands like Apple and Samsung closed their retail stores, a move that turned Back Market into a major supply channel. While offline retailers and carriers are shut down in Europe, Hug de Larauze says Chinese offline retailers and refurbishing factories are starting to get back to work.

R&D Roundup: Ultrasound/AI medical imaging, assistive exoskeletons and neural weather modeling

In the time of COVID-19, much of what transpires from the science world to the general public relates to the virus, and understandably so. But other domains, even within medical research, are still active — and as usual, there are tons of interesting (and heartening) stories out there that shouldn’t be lost in the furious activity of coronavirus coverage. This last week brought good news for several medical conditions as well as some innovations that could improve weather reporting and maybe save a few lives in Cambodia.

Ultrasound and AI promise better diagnosis of arrhythmia

Arrhythmia is a relatively common condition in which the heart beats at an abnormal rate, causing a variety of effects, including, potentially, death. Detecting it is done using an electrocardiogram, and while the technique is sound and widely used, it has its limitations: first, it relies heavily on an expert interpreting the signal, and second, even an expert’s diagnosis doesn’t give a good idea of what the issue looks like in that particular heart. Knowing exactly where the flaw is makes treatment much easier.

Ultrasound is used for internal imaging in lots of ways, but two recent studies establish it as perhaps the next major step in arrhythmia treatment. Researchers at Columbia University used a form of ultrasound monitoring called Electromechanical Wave Imaging to create 3D animations of the patient’s heart as it beat, which helped specialists predict 96% of arrhythmia locations compared with 71% when using the ECG. The two could be used together to provide a more accurate picture of the heart’s condition before undergoing treatment.

Another approach from Stanford applies deep learning techniques to ultrasound imagery and shows that an AI agent can recognize the parts of the heart and record the efficiency with which it is moving blood with accuracy comparable to experts. As with other medical imagery AIs, this isn’t about replacing a doctor but augmenting them; an automated system can help triage and prioritize effectively, suggest things the doctor might have missed or provide an impartial concurrence with their opinion. The code and data set of EchoNet are available for download and inspection.

Estimote launches wearables for workplace-level contact tracing for COVID-19

Bluetooth location beacon startup Estimote has adapted its technological expertise to develop a new product designed specifically at curbing the spread of COVID-19. The company created a new range of wearable devices that co-founder Steve Cheney believes can enhance workplace safety for those who have to be colocated at a physical workplace even while social distancing and physical isolation measures are in place.

The devices, called simply the “Proof of Health” wearables, aim to provide contact tracing – in other words, monitoring the potential spread of the coronavirus from person-to-person – at the level of a local workplace facility. The intention is to give employers a way to hopefully maintain a pulse on any possible transmission among their workforces and provide them with the ability to hopefully curtail any local spread before it becomes an outsized risk.

The hardware includes passive GPS location-tracking, as well as proximity sensors powered by Bluetooth and ultra-wide band radio connectivity, a rechargeable battery, and built-in LTE. It also includes a manual control to change a wearer’s health status, recording states like certified health, symptomatic, and verified infected. When a user updates their state to indicate possible or verified infection, that updates others they’ve been in contact with based on proximity and location-data history. This information is also stored in a health dashboard that provides detailed logs of possible contacts for centralized management. That’s designed for internal use within an organization for now, but Cheney tells me he’s working now to see if there might be a way to collaborate with WHO or other external health organizations to potentially leverage the information for tracing across enterprises and populations, too.

These are intended to come in a number of different form factors: the pebble-like version that exists today, which can be clipped to a lanyard for wearing and displaying around a person’s neck; a wrist-worn version with an integrated adjustable strap; and a card format that’s more compact for carrying and could work alongside traditional security badges often used for facility access control. The pebble-like design is already in production and 2,000 will be deployed now, with a plan to ramp production for as many as 10,000 more in the near future using the company’s Poland-based manufacturing resources.

Estimote has been building programmable sensor tech for enterprises for nearly a decade and has worked with large global companies, including Apple and Amazon . Cheney tells me that he quickly recognized the need for the application of this technology to the unique problems presented by the pandemic, but Estimote was already 18 months into developing it for other uses, including in hospitality industries for employee safety/panic button deployment.

“This stack has been in full production for 18 months,” he said via message. “We can program all wearables remotely (they’re LTE connected). Say a factory deploys this – we write an app to the wearable remotely. This is programmable IoT.

“Who knew the virus would require proof of health vis-a-vis location diagnostics tech,” he added.

Many have proposed technology-based solutions for contact tracing, including leveraging existing data gathered by smartphones and consumer applications to chart transmission. But those efforts also have considerable privacy implications, and require use of a smartphone – something that Cheney says isn’t really viable for accurate workplace tracking in high-traffic environments. By creating a dedicated wearable, Cheney says that Estimote can help employers avoid doing something “invasive” with their workforce, since it’s instead tied to a fit-for-purpose device with data shared only with their employers, and it’s in a form factor they can remove and have some control over. Mobile devices also can’t do nearly as fine-grained tracking with indoor environments as dedicated hardware can manage, he says.

And contact tracing at this hyperlocal level won’t necessarily just provide employers with early warning signs for curbing the spread earlier and more thoroughly than they would otherwise. In fact, larger-scale contact tracing fed by sensor data could inform new and improved strategies for COVID-19 response.

“Typically, contact tracing relies on the memory of individuals, or some high-level assumptions (for example, the shift someone worked),” said Brianna Vechhio-Pagán of John Hopkins University’s Applied Physics Lab via a statement. “New technologies can now track interactions within a transmissible, or ~6-foot range, thus reducing the error introduced by other methods. By combining very dense contact tracing data from Bluetooth and UWB signals with information about infection status and symptoms, we may discover new and improved ways to keep patients and staff safe.”

With the ultimate duration of measures like physical distancing essentially up-in-the-air, and some predictions indicating they’ll continue for many months, even if they vary in terms of severity, solutions like Estimote’s could become essential to keeping essential services and businesses operating while also doing the utmost to protect the health and safety of the workers incurring those risks. More far-reaching measures might be needed, too, including general-public-connected, contact-tracing programs, and efforts like this one should help inform the design and development of those.

Philter Labs nets additional funding in quest to build a better portable smoking filter

Philter Labs aims to reduce the stigma associated with vaping tobacco and cannabis. The company’s product is simple enough: It’s a portable filter that, to my surprise, eliminates nearly all secondhand smoke and vapor.

The company today is announcing an additional $1 million in funding from a private equity firm that invests in the cannabis industry. This round brings the San Diego-based company’s total funding to $3 million; it previously raised from Bravos Capital and Explorer Equity Group.

“PHILTER’s mission is to empower responsible adults with the choice to keep the air clean for those around them by filtering their emissions while still protecting a person’s right to vape,” said Philter Labs CEO Christos Nicolaidis. “This new funding allows us to continue to leverage science and our patented technology to eliminate secondhand smoke, reduce waste, and live out our mission to help lead a cultural shift for cleaner air and a better environment.”

The product works as advertised. Take a drag on a vape or joint or cigarette and exhale through the filter. The little filter then grabs all the particulate and, I guess, stores the bad stuff, leaving very little exiting the other side of the filter. Even the most considerable clouds of vapor disappear.

I tried both of the company’s current products, the Phlip ($30) and Pocket ($15). Both use the same filter. The difference is use. The Phlip is designed to put a filter alongside a vape pen. A silicon band ties the filter to most small vapes — it works fine with my Pax Era. This way, with the Phlip, the idea is a person inhales from one end and exhales through the other.

Does it eliminate all the smell and vapor? No, not totally, but the device makes a dramatic reduction.

There are similar products on the market. Smoke Buddy is a longtime favorite of mine, and these work in a similar fashion but have a more pocketable design. I’m more likely to carry this filter because it fits in a pocket without an issue.

There are no buttons to press or batteries to charge. The device is passive, and Philter Labs says each filter will last about 200 exhales. The company has filed half a dozen patents, with three recently being approved for upcoming products.

“Our mission is to inspire a change in the habits that are already out there,” John Grimm, co-inventor and CTO said. “We want to reduce emissions, not only to society but to the environment, and change smoking and vaping.”

Grimm explained that it’s more than reducing the harm. To him, it’s also about reducing the stigma that’s associated with smoking and vaping.

The system uses a propriety filtering process that breaks down the emissions at a molecular level through a five-step filtration process. The company says its technology captures and dissolves the particulates, pollutants and VOCs, which results in clean air exiting the filter.

I asked Grimm if the company has published a white paper on their findings. They have not; though he pointed out that Philter Labs founded a scientific advisory board (SSAB) that includes toxicologists formally from big tobacco, along with former executives from Dosist, Curaleaf and Juul.